Inactive Instrument
Progenics Pharmaceuticals, Inc. Stock
Stocks
US7431871067
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
David Mims
CEO | Chief Executive Officer | 62 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/19/20 | Issuer sale | Director | 170,000 | 0.1963% | ||
| 6/19/20 | Issuer sale | Director | 56,393 | 0.0651% | ||
| 6/19/20 | Issuer sale | Director | 106,393 | 0.1229% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +1.49% | - | - | 355M | |
| -1.92% | -1.57% | +48.70% | +84.37% | 55.92B | |
| +0.93% | +7.22% | +64.67% | +63.56% | 56.67B | |
| -2.97% | -2.44% | -22.05% | -17.74% | 23.28B | |
| -0.46% | -0.50% | +3.36% | +407.21% | 23.28B | |
| -0.36% | -0.56% | +36.00% | -3.93% | 20.54B | |
| -1.34% | -0.63% | +29.60% | -32.53% | 17.78B | |
| -1.44% | -1.63% | +37.07% | +589.93% | 15.9B | |
| -1.30% | -9.92% | +160.67% | +284.37% | 14.64B | |
| -0.50% | -0.56% | +21.96% | +181.21% | 13.99B | |
| Average | -0.94% | +0.47% | +42.22% | +172.94% | 26.89B | |
| Weighted average by Cap. | -0.89% | +1.47% | +43.26% | +135.56% |
Employees
-
